Study of HDM1002 drug interactions in healthy volunteers
This study tests how a new drug (HDM1002) interacts with two other common medicines—rifampin and itraconazole—in healthy volunteers. The results will help doctors understand how to safely use the drug with other medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good general health, as determined by a study doctor.
- You are between 18 and 45 years old.
- You weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female, and your body mass index (BMI) is between 19.0 and 32.0.
- You have no history of medullary thyroid cancer or related conditions in yourself or your family.
- You have not had pancreatitis, gallbladder issues, or stomach surgery that could affect digestion.
- You have not taken any medications that affect liver enzymes within the last 28 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a new medicine, HDM1002, interacts with four common drugs (repaglinide, atorvastatin, digoxin, rosuvastatin) in healthy and overweight adults. The results will help guide safe dosing for future patients.
This study looks at how the drug HDM1002 is absorbed by the body, both when taken with food and on an empty stomach. It helps researchers understand the best way to take the medication.
This study tests how a new drug called HDM1002 leaves the body, using a tiny amount of a radioactive marker. It's for healthy men, and the results will help researchers understand how the drug works.
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
This study tests how a new drug called HDM1002 interacts with common diabetes medications (metformin, empagliflozin) and other drugs like warfarin and valsartan. If you are a generally healthy adult (age 18-45) with a higher BMI, this trial helps ensure the new drug is safe when taken with other medicines.
This study tests how a new medication (HDM1005) affects the way your body absorbs and processes common drugs like metformin, atorvastatin, warfarin, and digoxin. It is for healthy volunteers to understand potential interactions before further testing.
Hear when a new Healthy Adult Subject trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.